| | 54571 | | 28.09.1999 | | Novo Nordisk Pharma AG | | 27.09.2004 | | | | | | | | | | 07.06.20. | | | | 07.06.20. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | NovoNorm 0,5 mg | Tabletten | Tablets (Repaglinide 0.5 mg) | A10BX02 | CI | 02 | NovoNorm 1,0 mg | Tabletten | Tablets (Repaglinide 1 mg) | A10BX02 | CI | 03 | NovoNorm 2,0 mg | Tabletten | Tablets (Repaglinide 2 mg) | A10BX02 | CI |
|
|